1. Home
  2. BCRX vs XHR Comparison

BCRX vs XHR Comparison

Compare BCRX & XHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • XHR
  • Stock Information
  • Founded
  • BCRX 1986
  • XHR 2007
  • Country
  • BCRX United States
  • XHR United States
  • Employees
  • BCRX N/A
  • XHR N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • XHR Real Estate Investment Trusts
  • Sector
  • BCRX Health Care
  • XHR Real Estate
  • Exchange
  • BCRX Nasdaq
  • XHR Nasdaq
  • Market Cap
  • BCRX 1.5B
  • XHR 1.5B
  • IPO Year
  • BCRX 1994
  • XHR N/A
  • Fundamental
  • Price
  • BCRX $7.45
  • XHR $14.93
  • Analyst Decision
  • BCRX Buy
  • XHR Buy
  • Analyst Count
  • BCRX 6
  • XHR 4
  • Target Price
  • BCRX $15.17
  • XHR $17.63
  • AVG Volume (30 Days)
  • BCRX 2.3M
  • XHR 711.4K
  • Earning Date
  • BCRX 02-24-2025
  • XHR 02-25-2025
  • Dividend Yield
  • BCRX N/A
  • XHR 3.23%
  • EPS Growth
  • BCRX N/A
  • XHR N/A
  • EPS
  • BCRX N/A
  • XHR 0.23
  • Revenue
  • BCRX $412,579,000.00
  • XHR $1,030,578,000.00
  • Revenue This Year
  • BCRX $38.01
  • XHR N/A
  • Revenue Next Year
  • BCRX $19.04
  • XHR $4.86
  • P/E Ratio
  • BCRX N/A
  • XHR $64.09
  • Revenue Growth
  • BCRX 29.92
  • XHR N/A
  • 52 Week Low
  • BCRX $4.03
  • XHR $12.34
  • 52 Week High
  • BCRX $8.88
  • XHR $16.50
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 47.51
  • XHR 47.54
  • Support Level
  • BCRX $7.53
  • XHR $14.88
  • Resistance Level
  • BCRX $8.02
  • XHR $15.13
  • Average True Range (ATR)
  • BCRX 0.44
  • XHR 0.29
  • MACD
  • BCRX -0.06
  • XHR 0.01
  • Stochastic Oscillator
  • BCRX 32.03
  • XHR 62.25

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About XHR Xenia Hotels & Resorts Inc.

Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The room segment contributes to the vast majority of the firm's total revenue. The firm's customer groups include transient business, group business, and contract business.

Share on Social Networks: